Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 6 min ago
Peer-reviewedCC BYThe Journal of clinical investigation

PI3K signaling in breast cancer: therapeutic advances versus adaptive resistance

  • Fabiana Napolitano1
  • Nisha Unni2
  • Carlos L. Arteaga2
  1. 1Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
  2. 2UT Southwestern Simmons Comprehensive Cancer Center and
Read full textPDFCite

Related

  1. Tumor Microenvironment-Mediated Resistance in HER2-Positive Breast Cancer: Recent Advances and Therapeutic Challenges
    Yutong Zhang, Xuanyi Lv, Zhihong Deng +9
    Oncology ResearchPeer-reviewedCC BY 4.0Full textOncologyPMC
  2. FOXM1 as a candidate dosage rheostat and state selector in breast cancer: linking multilevel regulation to adaptive plasticity and therapy resistance
    Ghaleb Oriquat, Hani Moslem Ahmed, Jasur Rizaev +4
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMC
  3. Endothelin signaling in diabetic kidney disease: therapeutic targeting and translational advances
    Li Ma, Wenhua Liu, Xiaotong Wang +2
    Frontiers in EndocrinologyPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossrefDOAJ
  4. Endocrine resistance in HR+/HER2− breast cancer: molecular mechanisms and emerging therapeutic strategies
    Tong Shen, Hui Li, Xubin Zhang +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMC
  5. Adaptive Rewiring of Nucleotide Metabolism in Therapeutic Resistance
    Bengisu Dayanc, Ganfei Xu, Xiaoshu Zhou +6
    CancersPeer-reviewedCC BY 4.0OncologyCrossref

Cite

BibTeXRIS
BibTeX
@article{napolitano2026pi3k,
  title = {{PI3K signaling in breast cancer: therapeutic advances versus adaptive resistance}},
  author = {Fabiana Napolitano and Nisha Unni and Carlos L. Arteaga},
  journal = {The Journal of clinical investigation},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13668639},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - PI3K signaling in breast cancer: therapeutic advances versus adaptive resistance
AU  - Fabiana Napolitano
AU  - Nisha Unni
AU  - Carlos L. Arteaga
PY  - 2026
DA  - 2026/10/19
JO  - The Journal of clinical investigation
UR  - https://europepmc.org/article/PMC/PMC13668639
SN  - 0021-9738
SN  - 1558-8238
ER  -